Company Encyclopedia
View More
name
KAISA HEALTH
00876.HK
Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People’s Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics and implant instruments.
74.22 B
00876.HKMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
C
Health Care SuppliesIndustry
Industry Ranking9/13
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-6.99%D
    • Profit Margin-18.76%D
    • Gross Margin36.21%C
  • Growth ScoreD
    • Revenue YoY-8.46%D
    • Net Profit YoY45.04%B
    • Total Assets YoY-9.63%E
    • Net Assets YoY-5.76%D
  • Cash ScoreD
    • Cash Flow Margin-533.12%E
    • OCF YoY-8.46%D
  • Operating ScoreD
    • Turnover0.31D
  • Debt ScoreA
    • Gearing Ratio16.01%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Morning Trend | KAISA HEALTH small-cap stocks see major player speculation, experiencing severe fluctuations under high pressure?

    KAISA HEALTH (876.HK) has recently experienced significant fluctuations in its trading, with golden cross signals igniting short-term bullish sentiment. The stock price once broke through previous highs, but intraday trading showed intense volatility, with the main positions rapidly switching their pace, leading to fierce short-term capital speculation. The company primarily focuses on health management and services, and its light asset model has attracted capital attention. The annual report data exceeded expectations, and short-term catalysts have driven active funds into small-cap stocks, but liquidity and capital concentration can easily become extreme, resulting in sharp market fluctuations. On the technical front, the 5, 10, and 20-day moving averages are in a bullish arrangement, providing effective support for the short term. If trading volume increases simultaneously and a high-level breakout is effective, the main players are expected to continue controlling the market. However, if large-scale sell-offs frequently occur during the session, the short-term may face a cooling pullback from high levels, potentially forming a defensive line at previous highs. The operational strategy suggests closely monitoring the flow of large orders in the market. Once a breakout with volume occurs, a small participation may be considered; otherwise, under severe fluctuations at high levels, a quick in-and-out strategy is advisable, with high selling and low buying to respond to the rotation of main positions. Overall, KAISA HEALTH is under pressure at its phase high, with the golden cross intensifying the battle between short-term main players entering and exiting. The market can reverse extremely quickly, making position management and risk control particularly important. Continuous attention should be paid to volume, the actions of main players during intraday trading, and the resonance of favorable policies

    Technical Forecast·
    HK
    00876
    -3.17%
    Technical Forecast·
    HK
    00876
    -3.17%

    Kaisa Health Group Holdings Ltd. Reports HK$88.5 Million Revenue and HK$24.3 Million Net Loss for Six Months Ended June 2024

    Kaisa Health Group Holdings Ltd. reported interim results for the six months ended June 30, 2025, with total revenue of HK$69.6 million, down from HK$88.5 million in 2024. The dental segment generated HK$66.4 million, a decrease from HK$85.9 million, while the health care segment increased to HK$3.1 million. The net loss narrowed to HK$9.3 million from HK$24.3 million. The total comprehensive income was HK$4.4 million, compared to a comprehensive expense of HK$34.2 million in the previous period. No significant updates on business operations were disclosed.

    Reuters·
    HK
    00876
    -3.17%
    Reuters·
    HK
    00876
    -3.17%

    Kaisa Health: Luo Tingting appointed as Vice Chairman of the Board

    According to the Zhitong Finance APP, KAISA HEALTH announced that Ms. Luo Tingting, Executive Director, has been appointed as Vice Chairman of the Board, effective from September 23, 2025

    Zhitong·
    HK
    00876
    -3.17%
    Zhitong·
    HK
    00876
    -3.17%

    Kaisa Health Group Updates Board of Directors

    Kaisa Health Group Holdings Limited (HK:0876) has updated its board of directors, effective from 23 September 2025. The announcement details the roles of executive and independent non-executive directors, along with the composition of key committees. This restructuring may affect the company's strategic direction and governance, impacting its market position. Kaisa Health Group focuses on health-related products and services, with a current market cap of HK$252.1M and a year-to-date price performance of 108.33%.

    Tip Ranks·
    HK
    00876
    -3.17%
    Tip Ranks·
    HK
    00876
    -3.17%

    Kaisa Health Group Holdings Ltd. Appoints Ms. Luo Tingting as Vice Chairperson of the Board

    Kaisa Health Group Holdings Ltd. has appointed Ms. Luo Tingting as the new Vice Chairperson of the Board, effective September 23, 2025. Ms. Luo, who has been with the company since April 2011, also serves as the chief financial officer and an executive director of Kaisa Group. She has previously held roles including general manager of the Planning and Finance Department and president assistant of Kaisa Group.

    Reuters·
    HK
    00876
    -3.17%
    Reuters·
    HK
    00876
    -3.17%